Indivior, US45579U1097

Indivior stock after-hours at EUR 31.50: plus 0.00 percent versus Lang & Schwarz prior close

Published on 10/02/2026 at 18:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Indivior stock was at EUR 31.50 in after-hours trading at 6:10 p.m. CEST on October 2, 2026, unchanged versus the Lang & Schwarz prior close. The company declared a contingent special dividend.

Moderne Pharma-Produktionsanlage mit Glasfassade und Industrieanlagen im Tageslicht
Indivior PLC mit ISIN GB00BYZ0C031 betreibt moderne Pharma-Produktionsanlage für innovative Suchtmedizin-Präparate weltweit an Patienten, Illustration mit AI erstellt.

Indivior stock was at EUR 31.50 in after-hours trading at 6:10 p.m. CEST on October 2, 2026. The price was unchanged, or plus 0.00 percent, versus the Lang & Schwarz prior close of EUR 31.50.

Indivior shares after the Xetra close

The latest after-hours price was recorded by Lang & Schwarz at 6:10 p.m. CEST. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Indivior stock.

Special dividend tied to Supernus merger

In a September 17, 2026 Form 8-K filed with the SEC, Indivior Pharmaceuticals, Inc. said its board had declared a special cash dividend of USD 8.13 per share. The dividend is payable to holders of record on October 30, 2026, but only if the company’s planned merger with Supernus Pharmaceuticals, Inc. closes.

The filing said the merger was expected to close on or about November 2, 2026, subject to required approvals and other closing conditions. If completed on that schedule, payment of the special dividend to eligible record holders was anticipated on or about November 6, 2026. Shares issued to Supernus stockholders as merger consideration would not qualify for the dividend.

Disclaimer...

en | US45579U1097 | INDIVIOR | boerse | 70216899 | bgmi